ResearchAarkstore Enterprise Breast Cancer Therapies Marketshttp://www.aarkstore.com/search/viewresults.asp?search=2012&Pu...
2.3 Risk Factors of Breast Cancer 172.3.1 Gender, Age and Reproductive Status 182.3.2 Genetic Mutation and Family History ...
3.2.9 Breast Cancer by Age and Ethnicity in the U.S. 363.2.10 U.S.: Early Detection of Breast Cancer 373.2.10.1 Breast Can...
http://www.facebook.com/aarkstoreenterprisehttp://in.linkedin.com/in/aarkstore Breast Cancer Therapies Markets HIV-AIDS Te...
Molecular Diagnostics MarketsMolecular Diagnostics in Cancer TestingDrugs of Abuse Testing MarketsUltrasound MarketsNuclea...
Upcoming SlideShare
Loading in …5
×

Research aarkstore enterprise breast cancer therapies markets

156 views
134 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
156
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Research aarkstore enterprise breast cancer therapies markets

  1. 1. ResearchAarkstore Enterprise Breast Cancer Therapies Marketshttp://www.aarkstore.com/search/viewresults.asp?search=2012&PubId=&pagenum=1http://www.aarkstore.com/search/viewresults.asp?search=Markets&PubId=&pagenum=1http://www.aarkstore.com/search/viewresults.asp?search=Cancer%20&PubId=&pagenum=1Breast cancer therapies are entering a new era as game-changers emerge for each of the majorbreast cancer patient populations. New market entrants must possess drug profiles and a savvyclinical development program to overcome such barriers to entry as a stringent regulatoryenvironment and the incursion of cost containment within oncology. This TriMark Publicationsreport provides comprehensive information on major and minor shapers of the breast cancerdrug treatment landscape. The study includes detailed discussions on the impact of criticalfactors, such as genericization, patent cliffs, drug shortages, reimbursement, predictive testingand personalized medicine, to help current and contemplative drug sponsors navigate thebreast cancer pharmacotherapeutic market. Moreover, this report contains a detailed analysisof each of the seven main modalities of breast cancer therapies, i.e., hormone therapy, surgery,radiation, molecular targeted therapy, chemotherapy, hormone treatment and targeted drugtherapy. Additionally, this study examines prescribing trends and the arrival of the firstbiosimilar agents and electronic records in post-marketing surveillance.Table of Contents :1. Overview 91.1 About This Report 91.2 Scope of This Report 91.3 Objectives 91.4 Methodology 101.5 Drugs Covered in This Report 111.6 Summary of Major Findings 132. About Breast Cancer 162.1 Tumorigenesis 162.2 Classification of Breast Cancer 17
  2. 2. 2.3 Risk Factors of Breast Cancer 172.3.1 Gender, Age and Reproductive Status 182.3.2 Genetic Mutation and Family History 192.3.3 Environmental Factors 192.3.4 Breast Density 202.4 The Various Options for Treating Breast Cancer 202.4.1 Prevention of Breast Cancer 202.4.2 Chemoprevention 202.4.3 Prophylactic Surgery 212.4.4 Radiation Therapy 212.4.5 Systemic Therapy 212.4.6 Targeted Therapy 212.4.7 Chemotherapy 222.4.8 Hormone Therapy 223. Global and Regional Data on Breast Cancer 233.1 Global Breast Cancer Statistics, 2012 233.2 Breast Cancer in the U.S. 283.2.1 U.S. Breast Cancer Statistics at a Glance 283.2.2 Breast Cancer Occurrence in the U.S. 293.2.3 Geographic Differences in Breast Cancer Rates in the U.S. 293.2.4 Breast Cancer Mortality Rate in the U.S. 313.2.5 Breast Cancer in the U.S. by Age 323.2.6 Changing Trends in In Situ Breast Cancer 323.2.7 Changing Trends in Invasive Breast Cancer in the U.S. 333.2.8 Breast Cancer in the U.S. by Tumor Size 34
  3. 3. 3.2.9 Breast Cancer by Age and Ethnicity in the U.S. 363.2.10 U.S.: Early Detection of Breast Cancer 373.2.10.1 Breast Cancer Screening in the U.S. 373.3 Breast Cancer in Canada 383.4 Breast Cancer Screening, Survival and Mortality in OECD Countries 393.5 Breast Cancer in U.K. 433.5.1 Female Breast Cancer by Age in U.K. 433.6 Breast Cancer in Australia 443.7 Breast Cancer in China 453.7.1 Treatment Patterns in China for Breast Cancer 463.8 Burden of Breast Cancer in India 493.9 Overview of Breast Cancer Incidence in Seven Major Markets 504. Pharmaceutical Drugs Used in Breast Cancer Treatment 514.1 Selected Classes of Chemotherapies 514.1.1 Chemotherapies Available as Generics 524.1.2 Branded Chemotherapies 544.2 Hormone Treatments 564.3 Targeted Drug Therapy 58For more information please visit link:http://www.aarkstore.com/reports/Breast-Cancer-Therapies-Markets-208193.htmlNeelAarkstore EnterprisePhone:08149852585Email:enquiry@aarkstore.comURL:www.aarkstore.com
  4. 4. http://www.facebook.com/aarkstoreenterprisehttp://in.linkedin.com/in/aarkstore Breast Cancer Therapies Markets HIV-AIDS Testing Markets Over-the-Counter Diagnostic Products World Markets DNA Sequencing and PCR Markets Medical Imaging Markets Clinical Laboratory Testing Volume 2: Key Players for Laboratory Testing, BusinessTrends and Strategies Clinical Laboratory Testing Volume 1: IVD Reagents and Instruments Markets Diabetes, Metabolic Syndrome and Cardiovascular Disease Catheter Markets Blood Glucose Testing and Diabetes Management Global Flow Cytometry Market U.S. Glucose Testing Markets High-Growth Diagnostic Testing Markets European Point of Care Diagnostic Testing Markets Disposable Syringe Markets Point of Care Diagnostic Testing World Markets Disposable Medical Supplies Markets Molecular Diagnostics in Infectious Disease Testing Companion Diagnostics in Personalized Medicine and Cancer Therapy World Glucose Self-Testing Markets Veterinary Health Markets Point of Care Diagnostic Testing Sector Trends Cardiac Marker Diagnostic Testing Markets Mass Spectroscopy for Clinical Laboratory Analysis Cardiac Rhythm Management Devices World Markets Picture Archiving and Communications Systems (PACS) Biomarker Technology Platforms for Cancer Diagnoses and Therapies Cancer Diagnostic Testing World Markets Positron Emission Tomography (PET) Markets
  5. 5. Molecular Diagnostics MarketsMolecular Diagnostics in Cancer TestingDrugs of Abuse Testing MarketsUltrasound MarketsNuclear Cardiology MarketsMedical Imaging BundleCancer Vaccines MarketsEuropean Medical Imaging MarketsRespiratory Therapeutics and Devices MarketsDiagnostics BundleMammography World MarketsIndias In Vitro Diagnostic Testing IndustryOrthopedics MarketsCell-Based Assays for Drug DiscoveryCytology and HPV Testing World MarketsClinical Chemistry AnalyzersClinical Immunoanalyzer MarketsMicroscopy MarketsAutomated Microbial Testing MarketsAnti-Infective Drugs MarketsPlastic Surgery Markets

×